ID | 543 |
No | 543 |
Brand Name | LOPID |
Ingredients | GEMFIBROZIL 300 MG |
Dosage Form | CAPSULE |
Primary Packaging | PVC-ALU BLISTER |
Storage | STORE BELOW 30'C |
Shelf Life | 60 MONTHS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | B04AC04 |
Pharmaceutical Class | LIPID MODIFYING |
Indications | GEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING :
PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV. |
Contraindications | GEMFIBROZIL IS CONTRAINDICATED IN PATIENTS WITH HEPATIC OR SEVERE RENAL DYSFUNCTION |
Side Effects | HEPATOBILIARY DISORDERS : CHLOESTATIC JAUNDICE |
Unit Price | USD 4.32 P |
EDL |
Yes |
Description | NO. 0 SNAP-FIT HARD GELATIN CAPSULES, WHITE OPAQUE BODY AND D-SCARLET OPAQUE CAP, BOVINE IMPRINTING-AXIAL ''PD 669'' AND ''LOPID TM'' IN GRAY CONTAINING A WHITE WAXY POWDER. |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | OLIC (THAILAND) LIMITED |
Country | THAILAND |
Import Registration No | 1A 420/40 |
Import Registration Date | 1997-05-29 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-03-06 |
FDD Registration No | 07 I 4016/14 |
FDD Registration Date | 2024-06-22 |
Expiry Date | 2027-06-21 |